Shilpa Biocare Partners with Gate2Brain to Target Pediatric Brain Cancers
Published on: June 8, 2026, 10:20 a.m. | Source: Devdiscourse
Shilpa Biocare Pvt Ltd has entered a strategic partnership with Gate2Brain to advance therapies for pediatric brain cancers. Aiming to bridge innovation with expertise, Shilpa will aid in manufacturing and regulatory aspects, supporting Gate2Brain's G2B-002 program, which uses novel technology for enhanced drug delivery.
